Hydrochloric Acid

Hydrochloric Acid

SCHEMBL27437167

Cl.OC1NCCO1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL299996 0.97
SCHEMBL24282474 0.80
SCHEMBL7776544 0.69
SCHEMBL7560953 0.65
SCHEMBL5197659 0.65
SCHEMBL214664 0.65 SLC6A2 (0.33)
SCHEMBL7545482 0.65 SLC6A2 (0.33)
Hydrochloric Acid SCHEMBL27502631 0.65
Hydrochloric Acid SCHEMBL28748183 0.65
SCHEMBL1053758 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102702184-A Novel oxazolidinone derivatives DONG A PHARM CO LTD 2012-10-03 CN claimed
CN-102516238-A Novel oxazolidinone derivatives DONG A PHARM CO LTD 2012-06-27 CN claimed
CN-1894242-A Novel oxazolidinone derivatives DONG A PHARM CO LTD (KR) 2007-01-10 CN claimed
CN-107709316-A The benzodioxan derivative of 2 (base of 1 heteroaryl piperazine 4) methyl 1,4 as α 2C antagonists 奥赖恩公司 2018-02-16 CN disclosed
CN-102516238-B Oxazolidinone derivative 东亚ST株式会社 2016-08-03 CN disclosed
CN-102702184-A Novel oxazolidinone derivatives DONG A PHARM CO LTD 2012-10-03 CN disclosed
CN-1894242-B Novel oxazolidinone derivatives DONG A PHARM CO LTD 2012-07-04 CN disclosed
CN-102516238-A Novel oxazolidinone derivatives DONG A PHARM CO LTD 2012-06-27 CN disclosed
CN-101982468-B Novel oxazolidinone derivatives and pharmaceutical compositions comprising the derivatives East-Asia Pharmaceutical Co., Ltd. (KR) 2012-02-08 CN disclosed
CN-101982468-A Novel oxazolidinone derivatives and pharmaceutical compositions comprising the derivatives DONG A PHARM CO LTD 2011-03-02 CN disclosed
CN-101910155-A Be used for the treatment of biphenyl derivatives with histamine-obstacle that the H3 receptor modulators is relevant as histamine-H3 receptor modulators ARENA PHARM INC 2010-12-08 CN disclosed
CN-1894242-A Novel oxazolidinone derivatives DONG A PHARM CO LTD (KR) 2007-01-10 CN disclosed
CN-1816534-A Oxazolidinone antibiotics and derivatives thereof MERCK & CO INC (US) 2006-08-09 CN disclosed
CN-1649866-A 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents ASTRAZENECA AB (SE) 2005-08-03 CN disclosed
CN-1165534-C Heterocyclyl amino methyloxazolidinones as antibacterials 2004-09-08 CN disclosed
CN-1322203-A Heterocyclic aminomethyl oxazolidinones as antibacterial agents ASTRA ZENECA N V (SE) 2001-11-14 CN disclosed
CN-1311787-A oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them ASTRA ZENECA CO LTD (SE) 2001-09-05 CN disclosed
CN-1161968-A Pyridine condensed thienyl- and furyl-oxazolidinone compounds BAYER AG (DE) 1997-10-15 CN disclosed
CN-1121919-A 5-membered heteroaryl-oxazoli-dinones BAYER AG (DE) 1996-05-08 CN disclosed
CN-1119647-A 6-membered nitrogen-containing heteroaryl-oxazolidinones BAYER AG (DE) 1996-04-03 CN disclosed